Eli Lilly has officially terminated its relationship with CVS Health, opting for Rightway as its new pharmacy benefit manager, according to a report from Bloomberg News. This strategic shift comes as part of Lilly’s ongoing efforts to enhance cost management and patient access to its medications.
The decision to switch pharmacy benefit managers reflects a broader trend within the pharmaceutical industry, where companies are reevaluating their partnerships to better align with evolving market demands and regulatory pressures. By choosing Rightway, Lilly aims to leverage innovative solutions that could streamline processes and improve patient outcomes.
This change could have significant implications for both Lilly and CVS Health, as it may influence pricing strategies and competitive dynamics in the pharmaceutical supply chain. As Lilly seeks to optimize its operations, other companies may follow suit, potentially reshaping the landscape of pharmacy benefit management in the coming years.
Open the full market picture for your next decision →
